| 1 |
GPL6660 |
Nsp copy number (CN) array (ds2) |
6,276,448 |
Affymetrix, Inc |
2008-03-27 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, Nsp copy number (CN) array (ds2), Research Array The Nsp copy number (CN) array contains 12,339,139 oligonucleotide probes tiled onto two arrays (ds1 and ds2 arrays). Probes were selected to represent each of the 1,330,354 fragments between 200-1100bp predicted to arise after digestion of human genomic DNA with the restriction enzyme NspI. Platform data table annotation based on genome build 35: hg17 (May 2004 build). |
| 2 |
GPL6659 |
Nsp copy number (CN) array (ds1) |
6,121,086 |
Affymetrix, Inc |
2008-03-27 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, Nsp copy number (CN) array (ds1), Research Array The Nsp copy number (CN) array contains 12,339,139 oligonucleotide probes tiled onto two arrays (ds1 and ds2 arrays). Probes were selected to represent each of the 1,330,354 fragments between 200-1100bp predicted to arise after digestion of human genomic DNA with the restriction enzyme NspI. Platform data table annotation based on genome build 35: hg17 (May 2004 build). |
| 3 |
GPL7026 |
Human Promoter Array 1.0R - NCBI build_35 |
5,150,820 |
University of Tokyo |
2008-07-07 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, Human Promoter Array 1.0R - NCBI build_35, For data analysis of the associated Samples, we calculated MAT scores based on the hyridization intensity data of the probes within 500bp windows. The coordinate column in the Platform data table represents the chromosome coordinates for the 500bp window center positions. |
| 4 |
GPL5295 |
AFFY Human Phase3 v1.0 - C62 |
4,919,563 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C62, |
| 5 |
GPL5249 |
AFFY Human Phase3 v1.0 - C16 |
4,422,670 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C16, |
| 6 |
GPL5267 |
AFFY Human Phase3 v1.0 - C34 |
4,320,474 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C34, |
| 7 |
GPL5246 |
AFFY Human Phase3 v1.0 - C13 |
4,240,896 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C13, |
| 8 |
GPL5250 |
AFFY Human Phase3 v1.0 - C17 |
4,120,959 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C17, |
| 9 |
GPL5235 |
AFFY Human Phase3 v1.0 - C02 |
4,053,015 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C02, |
| 10 |
GPL5306 |
AFFY Human Phase3 v1.0 - C73 |
3,959,283 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C73, |
| 11 |
GPL5290 |
AFFY Human Phase3 v1.0 - C57 |
3,943,778 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C57, |
| 12 |
GPL5284 |
AFFY Human Phase3 v1.0 - C51 |
3,878,895 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C51, |
| 13 |
GPL5260 |
AFFY Human Phase3 v1.0 - C27 |
3,855,826 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C27, |
| 14 |
GPL13490 |
Affymetrix Human Promoter 1.0R Array [genome build GRCh37] |
3,837,458 |
Medical University Innsbruck |
2011-05-04 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, Affymetrix Human Promoter 1.0R Array [genome build GRCh37], Custom probe annotation of Affymetrix Human Promoter 1.0R Tiling microarray. Annotation based on genome build GRCh37 (NCBI build 37; hg19). The data table contains only those probes that have a unique complete alignment to the genome, probes with multiple alignments or additional incomplete alignments (allowing 1 mis-match) were excluded. |
| 15 |
GPL5248 |
AFFY Human Phase3 v1.0 - C15 |
3,694,897 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C15, |
| 16 |
GPL5256 |
AFFY Human Phase3 v1.0 - C23 |
3,679,653 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C23, |
| 17 |
GPL5315 |
AFFY Human Phase3 v1.0 - C82 |
3,674,640 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C82, |
| 18 |
GPL5319 |
AFFY Human Phase3 v1.0 - C86 |
3,656,493 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C86, |
| 19 |
GPL5289 |
AFFY Human Phase3 v1.0 - C56 |
3,653,407 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C56, |
| 20 |
GPL5312 |
AFFY Human Phase3 v1.0 - C79 |
3,649,568 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
|
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C79, |
|